Global Noninvasive Cancer Diagnostics and Technology Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 88

Published Date: 15 Jun 2022

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Noninvasive Cancer Diagnostics and Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Noninvasive Cancer Diagnostics and Technology market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Medical Device Manufacturing Companies accounting for  % of the Noninvasive Cancer Diagnostics and Technology global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While Immunoassays segment is altered to a  % CAGR between 2022 and 2028.

Global key companies of Noninvasive Cancer Diagnostics and Technology include BIOVIEW Inc., Affymetrix Inc., Precision Therapeutics, Digene Corporation, and A&G Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over  % in 2021.

Market segmentation
Noninvasive Cancer Diagnostics and Technology market is split by Technology and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Technology and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Technology, covers
    Immunoassays
    Molecular Diagnostics
    Clinical Chemistry
    Other

Market segment by Application, can be divided into
    Medical Device Manufacturing Companies
    Hospitals and Clinics
    Oncology Laboratories
    Private Research Institutions
    Academic Institutions
    Pharmaceutical Companies
    Others

Market segment by players, this report covers
    BIOVIEW Inc.
    Affymetrix Inc.
    Precision Therapeutics
    Digene Corporation
    A&G Pharmaceutical
    Gen-Probe Incorporated
    AVIVA Biosciences Corporation
    Quest Diagnostics Incorporated
    Laboratory Corporation of America Holdings

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Noninvasive Cancer Diagnostics and Technology product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Noninvasive Cancer Diagnostics and Technology, with revenue, gross margin and global market share of Noninvasive Cancer Diagnostics and Technology from 2019 to 2022.
Chapter 3, the Noninvasive Cancer Diagnostics and Technology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Technology and application, with revenue and growth rate by Technology, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Noninvasive Cancer Diagnostics and Technology market forecast, by regions, technology and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Noninvasive Cancer Diagnostics and Technology research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Noninvasive Cancer Diagnostics and Technology
    1.2 Classification of Noninvasive Cancer Diagnostics and Technology by Technology
        1.2.1 Overview: Global Noninvasive Cancer Diagnostics and Technology Market Size by Technology: 2017 Versus 2021 Versus 2028
        1.2.2 Global Noninvasive Cancer Diagnostics and Technology Revenue Market Share by Technology in 2021
        1.2.3 Immunoassays
        1.2.4 Molecular Diagnostics
        1.2.5 Clinical Chemistry
        1.2.6 Other
    1.3 Global Noninvasive Cancer Diagnostics and Technology Market by Application
        1.3.1 Overview: Global Noninvasive Cancer Diagnostics and Technology Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Medical Device Manufacturing Companies
        1.3.3 Hospitals and Clinics
        1.3.4 Oncology Laboratories
        1.3.5 Private Research Institutions
        1.3.6 Academic Institutions
        1.3.7 Pharmaceutical Companies
        1.3.8 Others
    1.4 Global Noninvasive Cancer Diagnostics and Technology Market Size & Forecast
    1.5 Global Noninvasive Cancer Diagnostics and Technology Market Size and Forecast by Region
        1.5.1 Global Noninvasive Cancer Diagnostics and Technology Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Noninvasive Cancer Diagnostics and Technology Market Size by Region, (2017-2022)
        1.5.3 North America Noninvasive Cancer Diagnostics and Technology Market Size and Prospect (2017-2028)
        1.5.4 Europe Noninvasive Cancer Diagnostics and Technology Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Noninvasive Cancer Diagnostics and Technology Market Size and Prospect (2017-2028)
        1.5.6 South America Noninvasive Cancer Diagnostics and Technology Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Noninvasive Cancer Diagnostics and Technology Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Noninvasive Cancer Diagnostics and Technology Market Drivers
        1.6.2 Noninvasive Cancer Diagnostics and Technology Market Restraints
        1.6.3 Noninvasive Cancer Diagnostics and Technology Trends Analysis

2 Company Profiles
    2.1 BIOVIEW Inc.
        2.1.1 BIOVIEW Inc. Details
        2.1.2 BIOVIEW Inc. Major Business
        2.1.3 BIOVIEW Inc. Noninvasive Cancer Diagnostics and Technology Product and Solutions
        2.1.4 BIOVIEW Inc. Noninvasive Cancer Diagnostics and Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 BIOVIEW Inc. Recent Developments and Future Plans
    2.2 Affymetrix Inc.
        2.2.1 Affymetrix Inc. Details
        2.2.2 Affymetrix Inc. Major Business
        2.2.3 Affymetrix Inc. Noninvasive Cancer Diagnostics and Technology Product and Solutions
        2.2.4 Affymetrix Inc. Noninvasive Cancer Diagnostics and Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Affymetrix Inc. Recent Developments and Future Plans
    2.3 Precision Therapeutics
        2.3.1 Precision Therapeutics Details
        2.3.2 Precision Therapeutics Major Business
        2.3.3 Precision Therapeutics Noninvasive Cancer Diagnostics and Technology Product and Solutions
        2.3.4 Precision Therapeutics Noninvasive Cancer Diagnostics and Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Precision Therapeutics Recent Developments and Future Plans
    2.4 Digene Corporation
        2.4.1 Digene Corporation Details
        2.4.2 Digene Corporation Major Business
        2.4.3 Digene Corporation Noninvasive Cancer Diagnostics and Technology Product and Solutions
        2.4.4 Digene Corporation Noninvasive Cancer Diagnostics and Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Digene Corporation Recent Developments and Future Plans
    2.5 A&G Pharmaceutical
        2.5.1 A&G Pharmaceutical Details
        2.5.2 A&G Pharmaceutical Major Business
        2.5.3 A&G Pharmaceutical Noninvasive Cancer Diagnostics and Technology Product and Solutions
        2.5.4 A&G Pharmaceutical Noninvasive Cancer Diagnostics and Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 A&G Pharmaceutical Recent Developments and Future Plans
    2.6 Gen-Probe Incorporated
        2.6.1 Gen-Probe Incorporated Details
        2.6.2 Gen-Probe Incorporated Major Business
        2.6.3 Gen-Probe Incorporated Noninvasive Cancer Diagnostics and Technology Product and Solutions
        2.6.4 Gen-Probe Incorporated Noninvasive Cancer Diagnostics and Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Gen-Probe Incorporated Recent Developments and Future Plans
    2.7 AVIVA Biosciences Corporation
        2.7.1 AVIVA Biosciences Corporation Details
        2.7.2 AVIVA Biosciences Corporation Major Business
        2.7.3 AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics and Technology Product and Solutions
        2.7.4 AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics and Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 AVIVA Biosciences Corporation Recent Developments and Future Plans
    2.8 Quest Diagnostics Incorporated
        2.8.1 Quest Diagnostics Incorporated Details
        2.8.2 Quest Diagnostics Incorporated Major Business
        2.8.3 Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics and Technology Product and Solutions
        2.8.4 Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics and Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Quest Diagnostics Incorporated Recent Developments and Future Plans
    2.9 Laboratory Corporation of America Holdings
        2.9.1 Laboratory Corporation of America Holdings Details
        2.9.2 Laboratory Corporation of America Holdings Major Business
        2.9.3 Laboratory Corporation of America Holdings Noninvasive Cancer Diagnostics and Technology Product and Solutions
        2.9.4 Laboratory Corporation of America Holdings Noninvasive Cancer Diagnostics and Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Noninvasive Cancer Diagnostics and Technology Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Noninvasive Cancer Diagnostics and Technology Players Market Share in 2021
        3.2.2 Top 10 Noninvasive Cancer Diagnostics and Technology Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Noninvasive Cancer Diagnostics and Technology Players Head Office, Products and Services Provided
    3.4 Noninvasive Cancer Diagnostics and Technology Mergers & Acquisitions
    3.5 Noninvasive Cancer Diagnostics and Technology New Entrants and Expansion Plans

4 Market Size Segment by Technology
    4.1 Global Noninvasive Cancer Diagnostics and Technology Revenue and Market Share by Technology (2017-2022)
    4.2 Global Noninvasive Cancer Diagnostics and Technology Market Forecast by Technology (2023-2028)

5 Market Size Segment by Application
    5.1 Global Noninvasive Cancer Diagnostics and Technology Revenue Market Share by Application (2017-2022)
    5.2 Global Noninvasive Cancer Diagnostics and Technology Market Forecast by Application (2023-2028)

6 North America by Country, by Technology, and by Application
    6.1 North America Noninvasive Cancer Diagnostics and Technology Revenue by Technology (2017-2028)
    6.2 North America Noninvasive Cancer Diagnostics and Technology Revenue by Application (2017-2028)
    6.3 North America Noninvasive Cancer Diagnostics and Technology Market Size by Country
        6.3.1 North America Noninvasive Cancer Diagnostics and Technology Revenue by Country (2017-2028)
        6.3.2 United States Noninvasive Cancer Diagnostics and Technology Market Size and Forecast (2017-2028)
        6.3.3 Canada Noninvasive Cancer Diagnostics and Technology Market Size and Forecast (2017-2028)
        6.3.4 Mexico Noninvasive Cancer Diagnostics and Technology Market Size and Forecast (2017-2028)

7 Europe by Country, by Technology, and by Application
    7.1 Europe Noninvasive Cancer Diagnostics and Technology Revenue by Technology (2017-2028)
    7.2 Europe Noninvasive Cancer Diagnostics and Technology Revenue by Application (2017-2028)
    7.3 Europe Noninvasive Cancer Diagnostics and Technology Market Size by Country
        7.3.1 Europe Noninvasive Cancer Diagnostics and Technology Revenue by Country (2017-2028)
        7.3.2 Germany Noninvasive Cancer Diagnostics and Technology Market Size and Forecast (2017-2028)
        7.3.3 France Noninvasive Cancer Diagnostics and Technology Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Noninvasive Cancer Diagnostics and Technology Market Size and Forecast (2017-2028)
        7.3.5 Russia Noninvasive Cancer Diagnostics and Technology Market Size and Forecast (2017-2028)
        7.3.6 Italy Noninvasive Cancer Diagnostics and Technology Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Technology, and by Application
    8.1 Asia-Pacific Noninvasive Cancer Diagnostics and Technology Revenue by Technology (2017-2028)
    8.2 Asia-Pacific Noninvasive Cancer Diagnostics and Technology Revenue by Application (2017-2028)
    8.3 Asia-Pacific Noninvasive Cancer Diagnostics and Technology Market Size by Region
        8.3.1 Asia-Pacific Noninvasive Cancer Diagnostics and Technology Revenue by Region (2017-2028)
        8.3.2 China Noninvasive Cancer Diagnostics and Technology Market Size and Forecast (2017-2028)
        8.3.3 Japan Noninvasive Cancer Diagnostics and Technology Market Size and Forecast (2017-2028)
        8.3.4 South Korea Noninvasive Cancer Diagnostics and Technology Market Size and Forecast (2017-2028)
        8.3.5 India Noninvasive Cancer Diagnostics and Technology Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Noninvasive Cancer Diagnostics and Technology Market Size and Forecast (2017-2028)
        8.3.7 Australia Noninvasive Cancer Diagnostics and Technology Market Size and Forecast (2017-2028)

9 South America by Country, by Technology, and by Application
    9.1 South America Noninvasive Cancer Diagnostics and Technology Revenue by Technology (2017-2028)
    9.2 South America Noninvasive Cancer Diagnostics and Technology Revenue by Application (2017-2028)
    9.3 South America Noninvasive Cancer Diagnostics and Technology Market Size by Country
        9.3.1 South America Noninvasive Cancer Diagnostics and Technology Revenue by Country (2017-2028)
        9.3.2 Brazil Noninvasive Cancer Diagnostics and Technology Market Size and Forecast (2017-2028)
        9.3.3 Argentina Noninvasive Cancer Diagnostics and Technology Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Technology, and by Application
    10.1 Middle East & Africa Noninvasive Cancer Diagnostics and Technology Revenue by Technology (2017-2028)
    10.2 Middle East & Africa Noninvasive Cancer Diagnostics and Technology Revenue by Application (2017-2028)
    10.3 Middle East & Africa Noninvasive Cancer Diagnostics and Technology Market Size by Country
        10.3.1 Middle East & Africa Noninvasive Cancer Diagnostics and Technology Revenue by Country (2017-2028)
        10.3.2 Turkey Noninvasive Cancer Diagnostics and Technology Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Noninvasive Cancer Diagnostics and Technology Market Size and Forecast (2017-2028)
        10.3.4 UAE Noninvasive Cancer Diagnostics and Technology Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Noninvasive Cancer Diagnostics and Technology Revenue by Technology, (USD Million), 2017 VS 2021 VS 2028
    Table 2. Global Noninvasive Cancer Diagnostics and Technology Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
    Table 3. Global Market Noninvasive Cancer Diagnostics and Technology Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
    Table 4. Global Noninvasive Cancer Diagnostics and Technology Revenue (USD Million) by Region (2017-2022)
    Table 5. Global Noninvasive Cancer Diagnostics and Technology Revenue Market Share by Region (2023-2028)
    Table 6. BIOVIEW Inc. Corporate Information, Head Office, and Major Competitors
    Table 7. BIOVIEW Inc. Major Business
    Table 8. BIOVIEW Inc. Noninvasive Cancer Diagnostics and Technology Product and Solutions
    Table 9. BIOVIEW Inc. Noninvasive Cancer Diagnostics and Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 10. Affymetrix Inc. Corporate Information, Head Office, and Major Competitors
    Table 11. Affymetrix Inc. Major Business
    Table 12. Affymetrix Inc. Noninvasive Cancer Diagnostics and Technology Product and Solutions
    Table 13. Affymetrix Inc. Noninvasive Cancer Diagnostics and Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 14. Precision Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 15. Precision Therapeutics Major Business
    Table 16. Precision Therapeutics Noninvasive Cancer Diagnostics and Technology Product and Solutions
    Table 17. Precision Therapeutics Noninvasive Cancer Diagnostics and Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 18. Digene Corporation Corporate Information, Head Office, and Major Competitors
    Table 19. Digene Corporation Major Business
    Table 20. Digene Corporation Noninvasive Cancer Diagnostics and Technology Product and Solutions
    Table 21. Digene Corporation Noninvasive Cancer Diagnostics and Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 22. A&G Pharmaceutical Corporate Information, Head Office, and Major Competitors
    Table 23. A&G Pharmaceutical Major Business
    Table 24. A&G Pharmaceutical Noninvasive Cancer Diagnostics and Technology Product and Solutions
    Table 25. A&G Pharmaceutical Noninvasive Cancer Diagnostics and Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 26. Gen-Probe Incorporated Corporate Information, Head Office, and Major Competitors
    Table 27. Gen-Probe Incorporated Major Business
    Table 28. Gen-Probe Incorporated Noninvasive Cancer Diagnostics and Technology Product and Solutions
    Table 29. Gen-Probe Incorporated Noninvasive Cancer Diagnostics and Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 30. AVIVA Biosciences Corporation Corporate Information, Head Office, and Major Competitors
    Table 31. AVIVA Biosciences Corporation Major Business
    Table 32. AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics and Technology Product and Solutions
    Table 33. AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics and Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 34. Quest Diagnostics Incorporated Corporate Information, Head Office, and Major Competitors
    Table 35. Quest Diagnostics Incorporated Major Business
    Table 36. Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics and Technology Product and Solutions
    Table 37. Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics and Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 38. Laboratory Corporation of America Holdings Corporate Information, Head Office, and Major Competitors
    Table 39. Laboratory Corporation of America Holdings Major Business
    Table 40. Laboratory Corporation of America Holdings Noninvasive Cancer Diagnostics and Technology Product and Solutions
    Table 41. Laboratory Corporation of America Holdings Noninvasive Cancer Diagnostics and Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 42. Global Noninvasive Cancer Diagnostics and Technology Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
    Table 43. Global Noninvasive Cancer Diagnostics and Technology Revenue Share by Players (2019, 2020, 2021, and 2022)
    Table 44. Breakdown of Noninvasive Cancer Diagnostics and Technology by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 45. Noninvasive Cancer Diagnostics and Technology Players Head Office, Products and Services Provided
    Table 46. Noninvasive Cancer Diagnostics and Technology Mergers & Acquisitions in the Past Five Years
    Table 47. Noninvasive Cancer Diagnostics and Technology New Entrants and Expansion Plans
    Table 48. Global Noninvasive Cancer Diagnostics and Technology Revenue (USD Million) by Technology (2017-2022)
    Table 49. Global Noninvasive Cancer Diagnostics and Technology Revenue Share by Technology (2017-2022)
    Table 50. Global Noninvasive Cancer Diagnostics and Technology Revenue Forecast by Technology (2023-2028)
    Table 51. Global Noninvasive Cancer Diagnostics and Technology Revenue by Application (2017-2022)
    Table 52. Global Noninvasive Cancer Diagnostics and Technology Revenue Forecast by Application (2023-2028)
    Table 53. North America Noninvasive Cancer Diagnostics and Technology Revenue by Technology (2017-2022) & (USD Million)
    Table 54. North America Noninvasive Cancer Diagnostics and Technology Revenue by Technology (2023-2028) & (USD Million)
    Table 55. North America Noninvasive Cancer Diagnostics and Technology Revenue by Application (2017-2022) & (USD Million)
    Table 56. North America Noninvasive Cancer Diagnostics and Technology Revenue by Application (2023-2028) & (USD Million)
    Table 57. North America Noninvasive Cancer Diagnostics and Technology Revenue by Country (2017-2022) & (USD Million)
    Table 58. North America Noninvasive Cancer Diagnostics and Technology Revenue by Country (2023-2028) & (USD Million)
    Table 59. Europe Noninvasive Cancer Diagnostics and Technology Revenue by Technology (2017-2022) & (USD Million)
    Table 60. Europe Noninvasive Cancer Diagnostics and Technology Revenue by Technology (2023-2028) & (USD Million)
    Table 61. Europe Noninvasive Cancer Diagnostics and Technology Revenue by Application (2017-2022) & (USD Million)
    Table 62. Europe Noninvasive Cancer Diagnostics and Technology Revenue by Application (2023-2028) & (USD Million)
    Table 63. Europe Noninvasive Cancer Diagnostics and Technology Revenue by Country (2017-2022) & (USD Million)
    Table 64. Europe Noninvasive Cancer Diagnostics and Technology Revenue by Country (2023-2028) & (USD Million)
    Table 65. Asia-Pacific Noninvasive Cancer Diagnostics and Technology Revenue by Technology (2017-2022) & (USD Million)
    Table 66. Asia-Pacific Noninvasive Cancer Diagnostics and Technology Revenue by Technology (2023-2028) & (USD Million)
    Table 67. Asia-Pacific Noninvasive Cancer Diagnostics and Technology Revenue by Application (2017-2022) & (USD Million)
    Table 68. Asia-Pacific Noninvasive Cancer Diagnostics and Technology Revenue by Application (2023-2028) & (USD Million)
    Table 69. Asia-Pacific Noninvasive Cancer Diagnostics and Technology Revenue by Region (2017-2022) & (USD Million)
    Table 70. Asia-Pacific Noninvasive Cancer Diagnostics and Technology Revenue by Region (2023-2028) & (USD Million)
    Table 71. South America Noninvasive Cancer Diagnostics and Technology Revenue by Technology (2017-2022) & (USD Million)
    Table 72. South America Noninvasive Cancer Diagnostics and Technology Revenue by Technology (2023-2028) & (USD Million)
    Table 73. South America Noninvasive Cancer Diagnostics and Technology Revenue by Application (2017-2022) & (USD Million)
    Table 74. South America Noninvasive Cancer Diagnostics and Technology Revenue by Application (2023-2028) & (USD Million)
    Table 75. South America Noninvasive Cancer Diagnostics and Technology Revenue by Country (2017-2022) & (USD Million)
    Table 76. South America Noninvasive Cancer Diagnostics and Technology Revenue by Country (2023-2028) & (USD Million)
    Table 77. Middle East & Africa Noninvasive Cancer Diagnostics and Technology Revenue by Technology (2017-2022) & (USD Million)
    Table 78. Middle East & Africa Noninvasive Cancer Diagnostics and Technology Revenue by Technology (2023-2028) & (USD Million)
    Table 79. Middle East & Africa Noninvasive Cancer Diagnostics and Technology Revenue by Application (2017-2022) & (USD Million)
    Table 80. Middle East & Africa Noninvasive Cancer Diagnostics and Technology Revenue by Application (2023-2028) & (USD Million)
    Table 81. Middle East & Africa Noninvasive Cancer Diagnostics and Technology Revenue by Country (2017-2022) & (USD Million)
    Table 82. Middle East & Africa Noninvasive Cancer Diagnostics and Technology Revenue by Country (2023-2028) & (USD Million)
List of Figures
    Figure 1. Noninvasive Cancer Diagnostics and Technology Picture
    Figure 2. Global Noninvasive Cancer Diagnostics and Technology Revenue Market Share by Technology in 2021
    Figure 3. Immunoassays
    Figure 4. Molecular Diagnostics
    Figure 5. Clinical Chemistry
    Figure 6. Other
    Figure 7. Noninvasive Cancer Diagnostics and Technology Revenue Market Share by Application in 2021
    Figure 8. Medical Device Manufacturing Companies Picture
    Figure 9. Hospitals and Clinics Picture
    Figure 10. Oncology Laboratories Picture
    Figure 11. Private Research Institutions Picture
    Figure 12. Academic Institutions Picture
    Figure 13. Pharmaceutical Companies Picture
    Figure 14. Others Picture
    Figure 15. Global Noninvasive Cancer Diagnostics and Technology Market Size, (USD Million): 2017 VS 2021 VS 2028
    Figure 16. Global Noninvasive Cancer Diagnostics and Technology Revenue and Forecast (2017-2028) & (USD Million)
    Figure 17. Global Noninvasive Cancer Diagnostics and Technology Revenue Market Share by Region (2017-2028)
    Figure 18. Global Noninvasive Cancer Diagnostics and Technology Revenue Market Share by Region in 2021
    Figure 19. North America Noninvasive Cancer Diagnostics and Technology Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 20. Europe Noninvasive Cancer Diagnostics and Technology Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 21. Asia-Pacific Noninvasive Cancer Diagnostics and Technology Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 22. South America Noninvasive Cancer Diagnostics and Technology Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 23. Middle East and Africa Noninvasive Cancer Diagnostics and Technology Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 24. Noninvasive Cancer Diagnostics and Technology Market Drivers
    Figure 25. Noninvasive Cancer Diagnostics and Technology Market Restraints
    Figure 26. Noninvasive Cancer Diagnostics and Technology Market Trends
    Figure 27. BIOVIEW Inc. Recent Developments and Future Plans
    Figure 28. Affymetrix Inc. Recent Developments and Future Plans
    Figure 29. Precision Therapeutics Recent Developments and Future Plans
    Figure 30. Digene Corporation Recent Developments and Future Plans
    Figure 31. A&G Pharmaceutical Recent Developments and Future Plans
    Figure 32. Gen-Probe Incorporated Recent Developments and Future Plans
    Figure 33. AVIVA Biosciences Corporation Recent Developments and Future Plans
    Figure 34. Quest Diagnostics Incorporated Recent Developments and Future Plans
    Figure 35. Laboratory Corporation of America Holdings Recent Developments and Future Plans
    Figure 36. Global Noninvasive Cancer Diagnostics and Technology Revenue Share by Players in 2021
    Figure 37. Noninvasive Cancer Diagnostics and Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
    Figure 38. Global Top 3 Players Noninvasive Cancer Diagnostics and Technology Revenue Market Share in 2021
    Figure 39. Global Top 10 Players Noninvasive Cancer Diagnostics and Technology Revenue Market Share in 2021
    Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
    Figure 41. Global Noninvasive Cancer Diagnostics and Technology Revenue Share by Technology in 2021
    Figure 42. Global Noninvasive Cancer Diagnostics and Technology Market Share Forecast by Technology (2023-2028)
    Figure 43. Global Noninvasive Cancer Diagnostics and Technology Revenue Share by Application in 2021
    Figure 44. Global Noninvasive Cancer Diagnostics and Technology Market Share Forecast by Application (2023-2028)
    Figure 45. North America Noninvasive Cancer Diagnostics and Technology Sales Market Share by Technology (2017-2028)
    Figure 46. North America Noninvasive Cancer Diagnostics and Technology Sales Market Share by Application (2017-2028)
    Figure 47. North America Noninvasive Cancer Diagnostics and Technology Revenue Market Share by Country (2017-2028)
    Figure 48. United States Noninvasive Cancer Diagnostics and Technology Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. Canada Noninvasive Cancer Diagnostics and Technology Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. Mexico Noninvasive Cancer Diagnostics and Technology Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Europe Noninvasive Cancer Diagnostics and Technology Sales Market Share by Technology (2017-2028)
    Figure 52. Europe Noninvasive Cancer Diagnostics and Technology Sales Market Share by Application (2017-2028)
    Figure 53. Europe Noninvasive Cancer Diagnostics and Technology Revenue Market Share by Country (2017-2028)
    Figure 54. Germany Noninvasive Cancer Diagnostics and Technology Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 55. France Noninvasive Cancer Diagnostics and Technology Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 56. United Kingdom Noninvasive Cancer Diagnostics and Technology Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Russia Noninvasive Cancer Diagnostics and Technology Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. Italy Noninvasive Cancer Diagnostics and Technology Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. Asia-Pacific Noninvasive Cancer Diagnostics and Technology Sales Market Share by Technology (2017-2028)
    Figure 60. Asia-Pacific Noninvasive Cancer Diagnostics and Technology Sales Market Share by Application (2017-2028)
    Figure 61. Asia-Pacific Noninvasive Cancer Diagnostics and Technology Revenue Market Share by Region (2017-2028)
    Figure 62. China Noninvasive Cancer Diagnostics and Technology Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. Japan Noninvasive Cancer Diagnostics and Technology Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 64. South Korea Noninvasive Cancer Diagnostics and Technology Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 65. India Noninvasive Cancer Diagnostics and Technology Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 66. Southeast Asia Noninvasive Cancer Diagnostics and Technology Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. Australia Noninvasive Cancer Diagnostics and Technology Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. South America Noninvasive Cancer Diagnostics and Technology Sales Market Share by Technology (2017-2028)
    Figure 69. South America Noninvasive Cancer Diagnostics and Technology Sales Market Share by Application (2017-2028)
    Figure 70. South America Noninvasive Cancer Diagnostics and Technology Revenue Market Share by Country (2017-2028)
    Figure 71. Brazil Noninvasive Cancer Diagnostics and Technology Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 72. Argentina Noninvasive Cancer Diagnostics and Technology Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 73. Middle East and Africa Noninvasive Cancer Diagnostics and Technology Sales Market Share by Technology (2017-2028)
    Figure 74. Middle East and Africa Noninvasive Cancer Diagnostics and Technology Sales Market Share by Application (2017-2028)
    Figure 75. Middle East and Africa Noninvasive Cancer Diagnostics and Technology Revenue Market Share by Country (2017-2028)
    Figure 76. Turkey Noninvasive Cancer Diagnostics and Technology Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. Saudi Arabia Noninvasive Cancer Diagnostics and Technology Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 78. UAE Noninvasive Cancer Diagnostics and Technology Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 79. Methodology
    Figure 80. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

BIOVIEW Inc.
Affymetrix Inc.
Precision Therapeutics
Digene Corporation
A&G Pharmaceutical
Gen-Probe Incorporated
AVIVA Biosciences Corporation
Quest Diagnostics Incorporated
Laboratory Corporation of America Holdings

Related Reports

Global Noninvasive Cancer Diagnostics Technology Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Noninvasive Cancer Diagnostics Technology Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 17 May 2022

date Medical Devices & Consumables

The Noninvasive Cancer Diagnostics Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Noninvasive Cancer Diagnostics Technology Supply, Demand and Key Producers, 2023-2029

Global Noninvasive Cancer Diagnostics Technology Supply, Demand and Key Producers, 2023-2029

date 02 Sep 2023

date Medical Devices & Consumables

The global Noninvasive Cancer Diagnostics Technology market size is expected to reach $ 5810.7 million by 2029, rising at a market growth of 7.0% CAGR during the forecast period (2023-2029).

Global Noninvasive Cancer Diagnostics Technology Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Noninvasive Cancer Diagnostics Technology Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 02 Sep 2023

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Noninvasive Cancer Diagnostics Technology market size was valued at USD 3621.9 million in 2022 and is forecast to a readjusted size of USD 5810.7 million by 2029 with a CAGR of 7.0% during review period.

Global Noninvasive Cancer Diagnostics Technology Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Noninvasive Cancer Diagnostics Technology Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Noninvasive Cancer Diagnostics Technology market size was valued at USD 3621.9 million in 2023 and is forecast to a readjusted size of USD 5810.7 million by 2030 with a CAGR of 7.0% during review period.

Product Tags

noninvasive cancer diagnostics technology

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>